The Exit Strategy Acquisition for Consumer Biotech Companies

Video

The Exit Strategy Acquisition for Consumer Biotech Companies

The Exit Strategy Acquisition for Consumer Biotech Companies

Found this useful? Share it with someone in the field.

Today's Picks
A 10-Year Overnight Success: Building Twist Bioscience One Base at a Time
A 10-Year Overnight Success: Building Twist Bioscience One Base at a Time
Using Science to Remake Meat: The Next Agricultural Revolution
Using Science to Remake Meat: The Next Agricultural Revolution
Repairing Minds, Restoring Species: Biology’s Next Frontier
Repairing Minds, Restoring Species: Biology’s Next Frontier
Programmable Immunity: Engineering the Universal Antivenom
Programmable Immunity: Engineering the Universal Antivenom
From Cells to Patients: Solving the Scale Mismatch in Virtual Biology
From Cells to Patients: Solving the Scale Mismatch in Virtual Biology
Reprogramming Life: A Conversation on Longevity, Epigenetics, and the Future of Medicine
Reprogramming Life: A Conversation on Longevity, Epigenetics, and the Future of Medicine
How an Entrepreneur Built His Own R&D Loop, and Reached No Evidence of Disease
How an Entrepreneur Built His Own R&D Loop, and Reached No Evidence of Disease
From Models to Medicines: AI Meets the Next Generation of Drug Discovery
From Models to Medicines: AI Meets the Next Generation of Drug Discovery
2022 Keynote: Eric Schmidt
2022 Keynote: Eric Schmidt
2023 Annual Synthetic Biology Investment Report
2023 Annual Synthetic Biology Investment Report
Accelerating Bio R&D with New Funding Models
Accelerating Bio R&D with New Funding Models
AI and SynBio: The New Paradigm in Drug Discovery
AI and SynBio: The New Paradigm in Drug Discovery
A 10-Year Overnight Success: Building Twist Bioscience One Base at a Time
A 10-Year Overnight Success: Building Twist Bioscience One Base at a Time
Using Science to Remake Meat: The Next Agricultural Revolution
Using Science to Remake Meat: The Next Agricultural Revolution
Repairing Minds, Restoring Species: Biology’s Next Frontier
Repairing Minds, Restoring Species: Biology’s Next Frontier
Programmable Immunity: Engineering the Universal Antivenom
Programmable Immunity: Engineering the Universal Antivenom
From Cells to Patients: Solving the Scale Mismatch in Virtual Biology
From Cells to Patients: Solving the Scale Mismatch in Virtual Biology
Reprogramming Life: A Conversation on Longevity, Epigenetics, and the Future of Medicine
Reprogramming Life: A Conversation on Longevity, Epigenetics, and the Future of Medicine
How an Entrepreneur Built His Own R&D Loop, and Reached No Evidence of Disease
How an Entrepreneur Built His Own R&D Loop, and Reached No Evidence of Disease
From Models to Medicines: AI Meets the Next Generation of Drug Discovery
From Models to Medicines: AI Meets the Next Generation of Drug Discovery
2022 Keynote: Eric Schmidt
2022 Keynote: Eric Schmidt
2023 Annual Synthetic Biology Investment Report
2023 Annual Synthetic Biology Investment Report
Accelerating Bio R&D with New Funding Models
Accelerating Bio R&D with New Funding Models
AI and SynBio: The New Paradigm in Drug Discovery
AI and SynBio: The New Paradigm in Drug Discovery
Newsletter & More

SynBioBeta

2027

May 3-6,

2027

San Jose Convention Center ·

CA, USA

Event Details

Newsletter

Join List